Switch to हिंदी

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

हिंदी
  • Health A-Z
  • Diabetes
  • Diseases
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Cancer
    • Heart Attack
    • Pneumonia
    • Diseases A-Z
  • Diet & Fitness
    • Weight Management
    • Exercise & Body Building
    • Diet & Recipes
    • Yoga
  • Coronavirus
  • News
  • Pregnancy
    • Conceiving
    • Infertility
    • Labour & Delivery
    • Pregnancy week-by-week
    • Breastfeeding
    • Baby Names
  • Beauty
    • Skin
    • Hair
    • Grooming
  • Photos
  • Videos
Home / Health News / Sedative drugs, curb on family visits may increase risk of acute brain dysfunction in Covid-19 ICU patients

Sedative drugs, curb on family visits may increase risk of acute brain dysfunction in Covid-19 ICU patients

Many COVID-19 ICU patients experienced acute brain dysfunction that lasted for an average of 12 days, which is double what is seen in non-COVID ICU patients, finds a new study.

By: Longjam Dineshwori   | | Updated: January 12, 2021 10:22 am
Tags: Brain damage  Coronavirus  coronavirus pandemic  covid-19 complication  Delirium  
acute brain dysfunction in Covid-19 ICU patients
COVID-19 ICU patients receiving benzodiazepine sedative infusions were found to be at 59 per cent higher risk of developing delirium.

Covid-19 patients admitted to intensive care unit (ICU) are at increased risk of acute brain dysfunction, revealed a new study. They experienced a higher burden of delirium and coma than those hospitalised with acute respiratory failure, said the research published in The Lancet Respiratory Medicine journal. Also Read - Delhi health workers suffer mild reaction post COVID-19 vaccine: What you should expect 

The study, believed to be the largest of its kind to date, is led by scientists at Vanderbilt University Medical Center (VUMC) in the US. It tracked the incidence of delirium and coma in over 2,000 Covid-19 patients admitted to 69 adult ICUs across 14 countries before April 28, 2020. Nearly 82 per cent of these patients remained comatose for a median of 10 days, and 55 per cent were delirious for a median of three days. The acute brain dysfunction lasted for an average of 12 days, which is double what is seen in non-Covid ICU patients, noted study co-author Brenda Pun from VUMC. Also Read - Rapid blood test predicts COVID-19 patients at high risk of severe disease: Study



According to the scientists, ICU delirium can not only lead to higher medical costs but is associated greater risk of death and long-term ICU-related dementia. Also Read - ‘Contagious’ UK strain could become dominant COVID-19 variant by March 2021, warns CDC

Causes of acute brain dysfunction in Covid-19 ICU patients

While COVID-19 infection could predispose patients to a higher risk of acute brain dysfunction, patient care factors also appear to have played a significant role, said the researchers. They suspect that the choice of sedative medications and curbs on family visits also contributed to the increased risk of acute brain dysfunction in these patients.

It was found that many ICUs reverted to sedation practices that are not in line with best practice guidelines, leaving the scientists to speculate on the causes.

“Early reports of Covid-19 suggested that the lung dysfunction seen required unique management techniques including deep sedation. In the process, key preventive measures against acute brain dysfunction went somewhat by the boards,” news agency PTI quoted Pun as saying.

According to the study authors:

  • About 90 per cent of patients tracked in the study were invasively mechanical ventilated at some point during hospitalisation, and 67 per cent on the day of ICU admission.
  • Patients receiving benzodiazepine sedative infusions were at 59 per cent higher risk of developing delirium.
  • Patients who received family visitation were at 30 per cent lower risk of delirium

Senior author Pratik Pandharipande noted that these prolonged periods of acute brain dysfunction are largely avoidable if ICU teams return to lighter levels of sedation for these patients, along with frequent awakening and breathing trials, mobilisation and safe in-person or virtual visitation.

Covid-19 infection may cause irreversible brain damage

In the early months of the Covid-19 pandemic, doctors mainly focused on treating damage to the lungs and circulatory system of the patients. But they also noticed that some people hospitalized with severe Covid-19 experienced delirium, making them confused, disorientated and agitated. Later, several studies confirmed that infection with the novel coronavirus can cause damage to the brain as well and lead to neurological symptoms.

In April, a group of scientists in Japan published the first report of a Covid-19 patient who had swelling and inflammation in brain tissues. Another report described a Covid-19 patient with deterioration of myelin, a fatty coating that protects neurons.

A report published in Seizure: European Journal of Epilepsy in October 2020 also warned that infection with the novel coronavirus could lead to permanent brain damage. About one-third of Covid-19 patients studied had abnormalities in the frontal lobe of the brain, which researchers said might not be repaired after recovering from the disease.

 With inputs from PTI

Published : January 11, 2021 3:19 pm | Updated:January 12, 2021 10:22 am
Read Disclaimer

Holding breath to avoid Covid-19 infection? It may actually increase the risk, say Indian researchers

Holding breath to avoid Covid-19 infection? It may actually increase the risk, say Indian researchers

India records lowest Covid-19 infections in over 6 months: PM meeting CMs today to discuss vaccination rollout

India records lowest Covid-19 infections in over 6 months: PM meeting CMs today to discuss vaccination rollout

Please Wait. Article Loading ....

Coronavirus Updates

Coronavirus Updates

Stay Informed, Be Safe

  • Delhi health workers suffer mild reaction post COVID-19 vaccine: What you should expect 
  • Rapid blood test predicts COVID-19 patients at high risk of severe disease: Study
  • ‘Contagious’ UK strain could become dominant COVID-19 variant by March 2021, warns CDC
  • Separate consent form for Covaxin recipients: Compensation from Bharat Biotech in case of casualty
  • India launches world's largest Covid-19 vaccination drive: Who received the first shot?

Health Calculators

BMI Calculator
bmi Calculator
Ideal Body Weight
ideal body weight
Daily Calorie Intake
Daily calorie intake
Calories Burned
calories burned

Related Stories

Delhi health workers suffer mild reaction post COVID-19 vaccine: What you should expect 

Delhi health workers suffer mild reaction post COVID-19 vaccine: What you should expect 

Rapid blood test predicts COVID-19 patients at high risk of severe disease: Study

Rapid blood test predicts COVID-19 patients at high risk of severe disease: Study

‘Contagious’ UK strain could become dominant COVID-19 variant by March 2021, warns CDC

‘Contagious’ UK strain could become dominant COVID-19 variant by March 2021, warns CDC

Separate consent form for Covaxin recipients: Compensation from Bharat Biotech in case of casualty

Separate consent form for Covaxin recipients: Compensation from Bharat Biotech in case of casualty

India launches world's largest Covid-19 vaccination drive: Who received the first shot?

India launches world's largest Covid-19 vaccination drive: Who received the first shot?

Health News in Hindi

Bharat Biotech Covaxin Update: अन्य देशों को देने के लिए भारत बायोटेक से खरीदी जाएंगी 8.1 लाख कोवैक्सीन

Covid Vaccination In India: कोरोना टीकाकरण अभियान के पहले दिन 1.91 लाख लोगों को मिली वैक्सीन

Bird Flu in Delhi: दिल्ली में उल्लू, कबूतर और बगुलों में बर्ड फ्लू संक्रमण की पुष्टि

आखिर क्यों आरएमएल हॉस्पिटल के डॉक्टर्स भारत बायोटेक की ”कोवैक्सीन” की बजाय सीरम इंस्टीट्यूट की कोविशील्ड टीका लगवाने के लिए हैं तैयार, पढ़ें यहां

Corona Vaccine: नीति आयोग के सदस्य बोले- वैक्सीन सुरक्षित, अपने उत्पादों पर भरोसा रखें

Read All

Recent Posts

  • Mental illnesses on the rise in India: Know why and what you can do to fight the problem
  • Delhi health workers suffer mild reaction post COVID-19 vaccine: What you should expect 
  • Even minor forms of workplace mistreatment may up suicidal thoughts in employees
  • Rapid blood test predicts COVID-19 patients at high risk of severe disease: Study
  • Blood glucose level should be considered as ‘fifth vital sign’ during hospitalization: Indian docs

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com
+91 – 22 – 6697 1234
Landline Phone number 91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

Useful Links

  • Weight Loss
  • Keto Diet Tips
  • Skin Care Tips
  • Intermittent Fasting
  • Apple Cider Vinegar
  • Ashwagandha
  • Cancer
  • Pneumonia
  • Diarrhoea
  • Dengue
  • Typhoid
  • Tuberculosis
  • Chickenpox
  • Chikungunya
  • Depression
  • Hepatitis
  • Diabetes
  • Type 2 diabetes
  • Arthritis
  • Swine Flu
  • Baby Names
  • Cough and cold
  • Heart Attack
  • Breast Cancer
  • Ebola Virus
  • Dengue
  • Malaria
  • International Yoga Day
  • Hypotension
  • Heart Failure
  • Asthma
  • Brain Tumour
  • Celebrity Fitness
  • Goitre
  • HIV/AIDS

We respect your privacy

  • Disclaimer
  • Privacy Policy
  • Contact Us
  • Author Profiles

Copyright © 2021 Zee Entertainment Enterprises Limited. All rights reserved.